Effect and safety of conversion from Candesartan to Azilsartan in renal transplant recipeints
Not Applicable
- Conditions
- hypertensive patient
- Registration Number
- JPRN-UMIN000008989
- Lead Sponsor
- Soryukai Inoue Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Past medical history of hypersensitivity to azilsartan 2)Pregnant,lactating,and possibly pregnant women and those planning to become pregnant 3)Judged as ineligible by clinical investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine protein before,3 months,6 months,and 12 months after the conversion
- Secondary Outcome Measures
Name Time Method Blood pressure,albumin,creatinen,potasium,hemoglubin,plasma renin activity,plasma aldosterone concentarion and MCP-1 before,3 months,6 months,and 12 months after the conversion